BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Providência R, Paiva L, Barra S. Risk stratification of patients with atrial fibrillation: Biomarkers and other future perspectives. World J Cardiol 2012; 4(6): 195-200 [PMID: 22761972 DOI: 10.4330/wjc.v4.i6.195]
URL: https://www.wjgnet.com/1949-8462/full/v4/i6/195.htm
Number Citing Articles
1
Mahmoud Kamel Ahmed, Walaa Fared Abdelazez, Mofeed Ahmad Nasif. Assessment of left atrium mechanical function by deformation imaging in atrial fibrillation and its correlation with CHA2DS2-VASc risk scoreThe Egyptian Heart Journal 2015; 67(3): 209 doi: 10.1016/j.ehj.2014.08.001
2
W. El Borgi, S. Romdhane, W. Sdiri, S. Longo, R. Hafsia, M.R. Boujnah. Intérêt du dosage des d-dimères dans la fibrillation atriale non valvulaire. Première série prospective tunisienneAnnales de Cardiologie et d'Angéiologie 2015; 64(4): 279 doi: 10.1016/j.ancard.2015.01.003
3
J. A. Vílchez, V. Roldán, D. Hernández-Romero, M. Valdés, G. Y. H. Lip, F. Marín. Biomarkers in atrial fibrillation: an overviewInternational Journal of Clinical Practice 2014; 68(4): 434 doi: 10.1111/ijcp.12304
4
Ana I. Rodríguez-Serrano, María A. Esteve-Pastor, Diana Hernández-Romero, Mariano Valdés, Vanessa Roldán, Francisco Marín. Biomarkers in Cardiovascular Disease2015; : 1 doi: 10.1007/978-94-007-7741-5_36-1
5
Sarah C.W. Marott, Sune F. Nielsen, Marianne Benn, Børge G. Nordestgaard. Antihypertensive treatment and risk of atrial fibrillation: a nationwide studyEuropean Heart Journal 2014; 35(18): 1205 doi: 10.1093/eurheartj/eht507
6
Talal Moukabary, Mario D. Gonzalez. Management of Atrial FibrillationMedical Clinics of North America 2015; 99(4): 781 doi: 10.1016/j.mcna.2015.02.007
7
Ana I. Rodríguez-Serrano, María A. Esteve-Pastor, Diana Hernández-Romero, Mariano Valdés, Vanessa Roldán, Francisco Marín. Biomarkers in Cardiovascular Disease2016; : 507 doi: 10.1007/978-94-007-7678-4_36